TTNPB 通过调节染色质可访问性和S-(5'-腺) -L-homocysteine/胆代谢网络,促进人类多能干细胞向神经干细胞的转换
Ruilin Du1,2, Yudi Ren1,2, Qiaoqiao Meng1,2
1Research Center for Animal Genetic Resources of Mongolia Plateau, College of Life Sciences, Inner Mongolia University, Hohhot, China.
Advanced science (Weinheim, Baden-Wurttemberg, Germany)
|February 10, 2026
概括
研究人员开发了一种使用小分子有效地从人类多能干细胞 (PSCs) 创建先进的神经干细胞 (ANSCs) 的新方法. 这一突破有助于再生医学,并显示出治疗抑郁症的前景.
科学领域:
- 干细胞生物学 干细胞生物学
- 再生医学是一种再生医学.
- 神经科学是一个神经科学.
背景情况:
- 从人类多能干细胞 (PSC) 有效地获得神经干细胞 (NSC) 对再生医学应用至关重要.
- 目前的方法需要针对具有强大的神经谱系承诺的先进NSC种群进行优化.
研究的目的:
- 开发一种新的小分子策略,有效地从PSC诱导先进的神经干细胞 (ANSCs).
- 调查驱动神经分化的潜在表观遗传和代谢机制.
主要方法:
- 在化学定义的介质中,联合应用TTNPB (视网酸受体激动剂) 和CHIR99021 (GSK3β抑制剂).
- 全球染色体可访问性和基因表达的分析.
- 不针对性地对ANSCs进行代谢分析.
- 在老鼠抑郁模型中对ANSC移植和行为影响的功能评估.
主要成果:
- 成功诱导一个高度先进的NSC人群 (ANSCs) 从PSCs.
- 已证明TTNPB和CHIR99021可增强神经外皮基因表达和关键调节元件 (如PAX6,SOX1) 的染色质可访问性.
- 在ANSC中鉴定出一种独特的神经外皮相关的代谢状态,其中的关键代谢物 (例如胆) 能够诱导神经外皮标记物.
- 在老鼠抑郁症模型中显示ANSC移植恢复功能.
结论:
- 使用TTNPB和CHIR99021的新型小分子策略有效地从PSC产生ANSC.
- 表观遗传重塑和代谢重编程是驱动这种神经分化过程的关键机制.
- 这种方法对再生医学和神经系统疾病的治疗干预具有重大潜力.
更多相关视频
06:50Post-differentiation Replating of Human Pluripotent Stem Cell-derived Neurons for High-content Screening of Neuritogenesis and Synapse Maturation
Published on: August 28, 2019
9.0K
09:34Automated Production of Human Induced Pluripotent Stem Cell-Derived Cortical and Dopaminergic Neurons with Integrated Live-Cell Monitoring
Published on: August 6, 2020
6.9K
相关概念视频
01:29Somatic to iPS Cell Reprogramming
2.1K
Reprogramming alters the gene expression in somatic cells, transforming them into induced pluripotent stem (iPS) cells over several generations. Scientists can reprogram cells by introducing genes for four transcription factors—Oct4, Sox2, Klf4, and c-Myc (OSKM) by viral or non-viral methods. These factors are also known as Yamanaka factors after Shinya Yamanaka, who first generated iPS cells using mouse skin cells. Yamanaka was awarded the Nobel Prize in Physiology or Medicine in 2012...
2.1K
01:32Chromatin Modification in iPS Cells
1.5K
Chromatin modification alters gene expression; therefore, scientists can add histone-modifying enzymes, histone variants, and chromatin remodeling complexes to somatic cells to aid reprogramming into pluripotent stem (iPS) cells.
Compact chromatin makes reprogramming difficult. Enzymes, such as histone demethylases and acetyltransferases, are often added during reprogramming to loosen the chromatin, making the DNA more accessible to transcription factors. Molecules that inhibit histone...
Compact chromatin makes reprogramming difficult. Enzymes, such as histone demethylases and acetyltransferases, are often added during reprogramming to loosen the chromatin, making the DNA more accessible to transcription factors. Molecules that inhibit histone...
1.5K
01:24Methods of Nuclear Reprogramming
1.4K
Nuclear reprogramming is a process of transforming one cell type into an unrelated cell type by epigenetic changes that alter the cell’s original gene expression pattern. Such epigenetic changes force cells to express a different set of genes, which play a significant role in inducing transformation into other cell types. Nuclear reprogramming offers applications in reproductive cloning for livestock propagation and regenerative medicine — developing patient-specific cells for...
1.4K